SINCLAIR PHARMA CFO Matthew Hall is leaving the company.
Hall took the role of CFO at recent acquisition IS Pharma in 2009, having advised the company from 2007.
During the merger process earlier this year, Hall led the negotiation of a £16m debt facility from Clydesdale Bank on behalf of the enlarged group.
“Matthew’s dedication and hard work before and during the merger has been much appreciated, and he leaves Sinclair IS Pharma with the very best wishes of the board and our staff,” Sinclair said in a statement to stock exchange.
The business’ share price was static this morning at 30.75p.
Does Darwin's theory apply to taxation? Colin ponders...
The EC has been instructed to draft a European Union (EU) directive authorising an EU financial transaction tax, which would apply to ten of the EU’s 28 member states
The Financial Reporting Council has issued guidance regarding the annual reporting of 1,200 large and smaller listed companies. The letter highlighted the key issues and improvements that can be made in the 2016 reporting season
Baldwins Accountancy Group has continued investment in the north-east and appointed David Fish as a director in its corporate finance team